6694c2 tumor growth was equivalent among all groups (Fig. 6C), indicating that endogenous T cell responses to 6694c2 cells are insufficient and that DGKi/αPD-1 enhances antigen-specific immunity by transferred TRP1 T cells. The gene discussed is DGKI; the disease is neoplasm.